A clinically significant interaction between warfarin and simvastatin is unique to carriers of the C...
A clinically significant interaction between warfarin and simvastatin is unique to carriers of the CYP2C93 allele
About this item
Full title
Author / Creator
Publisher
England: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Simvastatin interacts with warfarin, but the strength of the interaction varies between individual patients, indicating a genetic predisposition.
The influence of the CYP2C9*2 and CYP2C9*3 polymorphisms on the interaction between simvastatin and warfarin was analyzed in data from 1132 patients.
Simvastatin use reduced warfarin dose requiremen...
Alternative Titles
Full title
A clinically significant interaction between warfarin and simvastatin is unique to carriers of the CYP2C93 allele
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1356930996
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1356930996
Other Identifiers
ISSN
1462-2416
E-ISSN
1744-8042
DOI
10.2217/pgs.12.40
